<DOC>
	<DOC>NCT00460577</DOC>
	<brief_summary>To determine efficacy and tolerability of inhaled Formoterol vs nebulized Ipatropioum Bromide plus Fenoterol in cumulative sequential doses in asthmatic children (5-&lt;12 years) with acute bronchial obstruction attending emergency services</brief_summary>
	<brief_title>Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-&lt;12 Years) With Acute Bronchial Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Fenoterol</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fenoterol, ipratropium drug combination</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Asthmatic children 5&lt;12 years old, requiring emergency services for acute bronchial obstruction mild to moderate determined by functional and clinical evidence Patients with severe acute bronchial obstruction determined by functional and clinical evidence Patients unable to use the inhaling device at time of treatment Patients who received a bronchodilator drug within the last 12 hours Patients who received inhaled steroids within the last 72 hours Patients who received systemic steroids within the last 7 days Patients with near fatal asthma history Patients with fever (&gt;38.5Â°C axillar temp) Patients with any clinical significance condition Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Asthma, Formoterol, Bronchial Obstruction, Children</keyword>
</DOC>